PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 117 filers reported holding PROVENTION BIO INC in Q3 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $32,291 | +621.7% | 1,339,905 | +216.5% | 0.02% | +800.0% |
| Q4 2022 | $4,474 | -97.4% | 423,295 | +895.1% | 0.00% | – |
| Q2 2022 | $170,000 | -94.5% | 42,540 | -92.2% | 0.00% | -100.0% |
| Q4 2021 | $3,070,000 | -38.8% | 546,202 | -30.3% | 0.00% | -33.3% |
| Q3 2021 | $5,015,000 | +5.5% | 783,522 | +39.0% | 0.00% | 0.0% |
| Q2 2021 | $4,752,000 | +34.8% | 563,688 | +67.8% | 0.00% | 0.0% |
| Q1 2021 | $3,526,000 | +39.9% | 335,961 | +125.8% | 0.00% | +50.0% |
| Q4 2020 | $2,521,000 | +25.7% | 148,808 | -4.8% | 0.00% | 0.0% |
| Q3 2020 | $2,006,000 | -77.1% | 156,320 | -74.8% | 0.00% | -83.3% |
| Q2 2020 | $8,763,000 | +64.3% | 621,070 | +7.1% | 0.01% | 0.0% |
| Q1 2020 | $5,335,000 | +859.5% | 579,866 | +1454.1% | 0.01% | +1100.0% |
| Q4 2019 | $556,000 | +283.4% | 37,313 | +75.0% | 0.00% | – |
| Q3 2019 | $145,000 | – | 21,324 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 14,879,023 | $157,271,273 | 9.67% |
| MPM BioImpact LLC | 898,483 | $9,496,965 | 2.46% |
| VR Adviser, LLC | 1,118,653 | $11,824,162 | 1.99% |
| Ghost Tree Capital, LLC | 400,000 | $4,228,000 | 1.80% |
| EAM Investors, LLC | 276,250 | $2,919,963 | 0.60% |
| EAM Global Investors LLC | 209,856 | $2,218,178 | 0.57% |
| 683 Capital Management, LLC | 550,000 | $5,813,500 | 0.49% |
| Palo Alto Investors LP | 390,800 | $4,130,756 | 0.35% |
| CABOT WEALTH MANAGEMENT INC | 184,271 | $1,948 | 0.33% |
| ADVISORY RESEARCH INC | 288,707 | $3,051,633 | 0.29% |